tiprankstipranks
I-Mab announces givastomig as lead program
PremiumThe FlyI-Mab announces givastomig as lead program
1M ago
I-Mab Biopharma’s Strategic Shift to US-Based Biotech
Premium
Company Announcements
I-Mab Biopharma’s Strategic Shift to US-Based Biotech
3M ago
I-Mab’s Third Quarter Results: Progress in Cancer Immunotherapies
Premium
Company Announcements
I-Mab’s Third Quarter Results: Progress in Cancer Immunotherapies
3M ago
Inhibrx prevails in trade secret case with I-Mab
PremiumThe FlyInhibrx prevails in trade secret case with I-Mab
4M ago
I-Mab Biopharma’s Strategic US Transition and Pipeline Focus
Premium
Company Announcements
I-Mab Biopharma’s Strategic US Transition and Pipeline Focus
4M ago
I-MAB Appoints New Board Member and Audit Committee
Premium
Company Announcements
I-MAB Appoints New Board Member and Audit Committee
5M ago
I-MAB Engages Interim CEO in Strategic Agreement
PremiumCompany AnnouncementsI-MAB Engages Interim CEO in Strategic Agreement
6M ago
I-Mab Highlights Pipeline Success and Strong Finances
Premium
Company Announcements
I-Mab Highlights Pipeline Success and Strong Finances
6M ago
I-Mab Announces New Auditor for Strategic Growth
Premium
Company Announcements
I-Mab Announces New Auditor for Strategic Growth
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100